I. Gurevic's research works | University of Wisconsin–Madison, Wisconsin (UW) and other places

What is this page?

This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

THE EPITHELIAL NICHE TROPHIC SECRETOME OF CULTURE-ADAPTED MESENCHYMAL STROMAL CELLS DIFFERS BY TISSUE SOURCE AND CYTOKINE TREATMENT

Article

Jun 2024

Early Treatment With Mesenchymal Stromal Cells Prevents Development of Long-term Radiation Induced Salivary Dysfunction

Article

Apr 2024

Mesenchymal Stem/Stromal Cells: THE EPITHELIAL NICHE TROPHIC SECRETOME OF CULTURE-ADAPTED MESENCHYMAL STROMAL CELLS DIFFERS BY TISSUE SOURCE

Article

May 2023

Mesenchymal Stem/Stromal Cells: TARGETING ENDOGENOUS MESENCHYMAL STROMAL CELL RESPONSE TO INTERFERONγ IN SJÖGREN’S

Article

May 2022

Ruxolitinib Inhibits IFNγ-stimulated Sjögren's Salivary Gland MSC HLA-DR Expression and Chemokine-Dependent T-cell Migration

Article

Feb 2022

Objectives: Sjӧgren's disease (SjD) is a systemic autoimmune disease characterized by focal lymphocytic infiltrate of salivary glands (SGs) and high SG IFNγ, both of which are associated with elevated lymphoma risk. IFNγ is also biologically relevant to mesenchymal stromal cells (MSCs), a SG resident cell with unique niche regenerative and immunor...

Targeting endogenous mesenchymal stromal cell response to interferon γ in sjögren’s syndrome

Article